GURUFOCUS.COM » STOCK LIST » Technology » Hardware » DorsaVi Ltd (ASX:DVL) » Definitions » Tax Expense

DorsaVi (ASX:DVL) Tax Expense : A$-0.39 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is DorsaVi Tax Expense?

DorsaVi's tax expense for the months ended in Dec. 2024 was A$-0.17 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.39 Mil.


DorsaVi Tax Expense Historical Data

The historical data trend for DorsaVi's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DorsaVi Tax Expense Chart

DorsaVi Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.46 -0.42 -0.56 -0.49 -0.46

DorsaVi Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.22 -0.24 -0.22 -0.17

DorsaVi Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DorsaVi  (ASX:DVL) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


DorsaVi Tax Expense Related Terms

Thank you for viewing the detailed overview of DorsaVi's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


DorsaVi Business Description

Traded in Other Exchanges
N/A
Address
11-13 Milgate Street, Unit 3, Oakleigh South, Melbourne, VIC, AUS, 3167
DorsaVi Ltd is engaged in the development and sale of motion analysis technologies. Its technologies are commercialized via license, sale, or fixed-fee consultancy. The company makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), and others. The firm operates in two reportable segments: Clinical, and Workplace. A majority of its revenue is generated from the Clinical segment. Geographically, the company derives maximum revenue from the United States of America, and the rest from Australia, and Europe.

DorsaVi Headlines

No Headlines